Recent advances in neutralizing the IL-6 pathway in arthritis
Charles J MalemudDivision of Rheumatic Diseases, Case Western Reserve University, School of Medicine and University Hospitals Case Medical Center, Cleveland, Ohio, USAAbstract: Recent advances in understanding the mechanism(s) of how IL-6 trans-signaling regulates immune cell function and promotes i...
Guardado en:
Autor principal: | Charles J Malemud |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b7c2345493cb47778126e13428d3e1db |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The patient perspective: arthritis care provided by Advanced Clinician Practitioner in Arthritis Care program-trained clinicians
por: Warmington K, et al.
Publicado: (2015) -
Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis
por: Masahiko Mihara, et al.
Publicado: (2011) -
Reappraisal of the clinical use of leflunomide in rheumatoid arthritis and psoriatic arthritis
por: Peter BB Jones, et al.
Publicado: (2010) -
Rheumatoid arthritis: Disease or syndrome?
por: Jessica A Stanich, et al.
Publicado: (2009) -
Treatment of systemic-onset juvenile arthritis with canakinumab
por: Peitz J, et al.
Publicado: (2015)